Seokjoong Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Targeted KEAP1 disruption enhances antioxidant defense and mesenchymal stromal cell therapy for chronic limb-threatening ischemia.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 20, 2025
CRISPR-Cas9 knockout of DGKα/ζ improves the anti-tumor activities of TAG-72 CAR-T cells in ovarian cancer.
Journal: Molecular therapy. Oncology
Published: August 30, 2024
Identification AAVS1-like locus from the porcine genome and site-specific integration of recombinase-mediated cassette exchange using CRISPR/Cas9.
Journal: Animal biotechnology
Published: March 11, 2023
In vivo genome editing for hemophilia B therapy by the combination of rebalancing and therapeutic gene knockin using a viral and non-viral vector.
Journal: Molecular therapy. Nucleic acids
Published: November 14, 2022
Statins suppress cell-to-cell propagation of α-synuclein by lowering cholesterol.
Journal: Cell death & disease
Published: October 30, 2022
Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery.
Journal: Experimental & molecular medicine
Published: August 18, 2022
Author Correction : SUPT4H1-edited stem cell therapy rescues neuronal dysfunction in a mouse model for Huntington's disease.
Journal: NPJ Regenerative medicine
Published: April 22, 2022
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy.
Journal: Science advances
Published: January 21, 2022
Genome editing-mediated knock-in of therapeutic genes ameliorates the disease phenotype in a model of hemophilia.
Journal: Molecular therapy. Nucleic acids
Published: January 05, 2022
SUPT4H1-edited stem cell therapy rescues neuronal dysfunction in a mouse model for Huntington's disease.
Journal: NPJ Regenerative medicine
Published: November 10, 2020
Efficient and specific generation of knockout mice using Campylobacter jejuni CRISPR/Cas9 system.
Journal: Biochemistry and biophysics reports
Published: October 11, 2019
Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.
Journal: Nucleic acids research
Published: May 05, 2019
Last Updated: 09/26/2026